Drawing for BACFENSSI

USPTO serial 79320158

BACFENSSI

Reviewed by CopyMark Law Group

Reg. 6829818Status 700Registered
Filing date
Status date
Registration date
Aug 30, 2022
Examiner
SOLANO, CARLITA JAYE
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with BACFENSSI?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Bharati Bakshani

Bharati Bakshani Ladas & Parry, LLP1040 Avenue of the AmericasNew York, NY 10018UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Drug carriers for medical use, namely, polymer-lipid matrix formulation for localized drug delivery; drug delivery formulations for medical use, namely, drug delivery agents in the form of polymer-lipid matrix for sustained drug delivery; drug delivery formulations for medical use, namely, drug delivery formulations being drug delivery agents in the form of powders and pastes that provide sustained release of the active ingredients for a wide variety of pharmaceuticals; antibiotic delivery systems comprising polymer-lipid based matrix formulation for the continuous release of antibiotic drugs for medical use, namely for the prevention and treatment of infections associated with surgical procedures; drug delivery systems for medical use, namely, drug delivery agents being polymeric based particles coated with polymer-lipid matrix for sustained antibiotic drug delivery; drug delivery systems for medical use, namely, drug delivery agents being polymeric based particles impregnated with polymer-lipid matrix for sustained antibiotic drug delivery; drug delivery systems for medical use, namely, drug delivery agents being mineral based particles coated with polymer-lipid matrix for sustained antibiotic drug delivery; drug delivery systems for medical use, namely, drug delivery agents being mineral based particles impregnated with polymer-lipid matrix for sustained antibiotic drug deliveryACTIVE—
010Drug delivery systems for medical use, namely, surgical instruments and materials being sutures, orthopedic and dental nails, screws, staples, wires, pins, sponges, metal and polymeric implants, all coated with polymer-lipid matrix for sustained drug delivery; Drug delivery systems for medical use, namely, surgical instruments and materials being sutures, orthopedic and dental nails, screws, staples, wires, pins, sponges, metal and polymeric implants, all impregnated with polymer-lipid matrix for sustained antibiotic drug delivery; Drug delivery systems for medical use, namely, surgical instruments and materials being sutures, orthopedic and dental nails, screws, staples, wires, pins, sponges, metal and polymeric implants, all coated with polymer-lipid matrix for sustained antibiotic drug deliveryACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 4, 2023FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Dec 9, 2022FICSFINAL DISPOSITION NOTICE SENT TO IB—
Dec 9, 2022FIMPFINAL DISPOSITION PROCESSED—
Nov 30, 2022FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Aug 30, 2022NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Aug 30, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 14, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 14, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 25, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 6, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 6, 2022XAECEXAMINER'S AMENDMENT ENTERED—
May 6, 2022GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
May 6, 2022GNEAEXAMINERS AMENDMENT E-MAILED—
May 6, 2022CNEAEXAMINERS AMENDMENT -WRITTEN—
May 6, 2022XAECEXAMINER'S AMENDMENT ENTERED—
May 6, 2022CNEAEXAMINERS AMENDMENT -WRITTEN—
Apr 8, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 7, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 7, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 15, 2021RFNTREFUSAL PROCESSED BY IB—
Oct 28, 2021RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Oct 28, 2021RFRRREFUSAL PROCESSED BY MPU—
Oct 25, 2021RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Oct 24, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 19, 2021DOCKASSIGNED TO EXAMINER—
Sep 24, 2021MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 20, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 16, 2021REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance